Literature DB >> 16684290

Oculocutaneous tyrosinaemia or tyrosinaemia type 2: a case report.

M Valikhani1, M Akhyani, A K Jafari, M Barzegari, S Toosi.   

Abstract

Oculo-cutaneous tyrosinaemia type II is an autosomal recessive disease due to an abnormality of tyrosine metabolism, probably because of a deficiency of cytoplasmic tyrosine aminotransferase. It presents as a varying association of focal palmoplantar keratosis, bilateral keratitis and mental retardation. Herein, we report an 8-year-old boy with palmoplantar hyperkeratosis with peripheral oozing and dendritic keratitis appearing after the skin lesions. There was no mental deterioration despite the long delay in diagnosis of the disorder. The diagnosis was confirmed by the presence of hypertyrosinaemia and the absence of hepatorenal lesion. The child exhibited a remarkable degree of improvement in the hyperkeratotic lesions and keratitis after the dietary modifications were instituted. In conclusion, chronic focal bullous palmoplantar hyperkeratosis along with keratitis should alert the clinician to screen for abnormal serum and/or urine tyrosine level. Awareness of the presenting signs and symptoms may speed up the diagnosis and initiation of a tyrosine and phenylalanine-restricted diet that is most efficient in improving the symptoms and preventing visual and cognitive impairment.

Entities:  

Mesh:

Year:  2006        PMID: 16684290     DOI: 10.1111/j.1468-3083.2006.01572.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  11 in total

1.  Antioxidants reverse the changes in energy metabolism of rat brain after chronic administration of L.-tyrosine.

Authors:  Brena P Teodorak; Giselli Scaini; Milena Carvalho-Silva; Lara M Gomes; Letícia J Teixeira; Joyce Rebelo; Samira D T De Prá; Neila Zeni; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2016-12-06       Impact factor: 3.584

2.  The characterization of neuroenergetic effects of chronic L-tyrosine administration in young rats: evidence for striatal susceptibility.

Authors:  Gabriela K Ferreira; Milena Carvalho-Silva; Lara M Gomes; Giselli Scaini; Leticia J Teixeira; Isabella T Mota; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2014-09-25       Impact factor: 3.584

3.  Omega-3 fatty acid supplementation can prevent changes in mitochondrial energy metabolism and oxidative stress caused by chronic administration of L-tyrosine in the brain of rats.

Authors:  Milena Carvalho-Silva; Lara M Gomes; Maria L Gomes; Bruna K Ferreira; Patricia F Schuck; Gustavo C Ferreira; Felipe Dal-Pizzol; Jade de Oliveira; Giselli Scaini; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2019-04-04       Impact factor: 3.584

4.  TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping.

Authors:  G Maydan; B S Andresen; P P Madsen; M Zeigler; A Raas-Rothschild; A Zlotogorski; A Gutman; S H Korman
Journal:  J Inherit Metab Dis       Date:  2006-08-17       Impact factor: 4.982

5.  Role of antioxidant treatment on DNA and lipid damage in the brain of rats subjected to a chemically induced chronic model of tyrosinemia type II.

Authors:  Emilio L Streck; Samira D T De Prá; Paula Ronsani Ferro; Milena Carvalho-Silva; Lara M Gomes; Jotele F Agostini; Adriani Damiani; Vanessa M Andrade; Patrícia F Schuck; Gustavo C Ferreira; Giselli Scaini
Journal:  Mol Cell Biochem       Date:  2017-05-25       Impact factor: 3.396

6.  An evaluation of the effects of acute and chronic L-tyrosine administration on BDNF levels and BDNF mRNA expression in the rat brain.

Authors:  Gabriela K Ferreira; Giselli Scaini; Isabela C Jeremias; Milena Carvalho-Silva; Cinara L Gonçalves; Talita C B Pereira; Giovanna M T Oliveira; Luiza W Kist; Maurício R Bogo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2013-10-04       Impact factor: 5.590

7.  Effect of L-tyrosine in vitro and in vivo on energy metabolism parameters in brain and liver of young rats.

Authors:  Gabriela K Ferreira; Giselli Scaini; Milena Carvalho-Silva; Lara M Gomes; Lislaine S Borges; Júlia S Vieira; Larissa S Constantino; Gustavo C Ferreira; Patrícia F Schuck; Emilio L Streck
Journal:  Neurotox Res       Date:  2012-07-31       Impact factor: 3.911

8.  Creatine and pyruvate prevent the alterations caused by tyrosine on parameters of oxidative stress and enzyme activities of phosphoryltransfer network in cerebral cortex of Wistar rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Narielle Ferner Bonorino; Bruna May Lopes Costa; Cláudia Funchal; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Mol Neurobiol       Date:  2014-06-25       Impact factor: 5.590

9.  Tyrosine administration decreases glutathione and stimulates lipid and protein oxidation in rat cerebral cortex.

Authors:  Angela M Sgaravatti; Alessandra S Magnusson; Amanda S de Oliveira; Andréa P Rosa; Caroline Paula Mescka; Fernanda R Zanin; Carolina D Pederzolli; Angela T S Wyse; Clóvis M D Wannmacher; Moacir Wajner; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2009-08-18       Impact factor: 3.584

10.  Effect of acute and chronic administration of L-tyrosine on nerve growth factor levels in rat brain.

Authors:  Gabriela K Ferreira; Isabela C Jeremias; Giselli Scaini; Milena Carvalho-Silva; Lara M Gomes; Camila B Furlanetto; Meline O Morais; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Neurochem Res       Date:  2013-05-21       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.